Gregory S Moran, NP
Nurse Practitioner · Boise
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
- Since medical school
- 13 years
- University of Missouri, Columbia School of Medicine, 2013
Offices
6 locations · St Lukes Clinic-Treasure Valley LLC · 1,155 clinicians in this group
Looking this up.
Hospitals listed: St Luke'S Nampa Medical Center · St Luke'S Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Gregory S Moran’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A23215 · Deceased
Licence status: Deceased · since 1969 · University of Guadalajara Faculty of Medicine.
Licensee is deceased.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- St Luke'S Nampa Medical CenterNampa, IDAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Saint Lukes, which runs 9 hospitalsPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.25, Oct 2024 – Sep 2025
- St Luke'S Regional Medical CenterBoise, IDAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Saint Lukes, which runs 9 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.459, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.203, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.407, Oct 2024 – Sep 2025Better than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 8.1 (6.8 to 9.7) · 1,092 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for St Luke'S Nampa Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.25 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.08) · 248 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.57 to 1.46) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.2 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 166 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 7.6 · 149 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,239 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,590 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,581 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.56 (1.07 to 6.05) · 231 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 42 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.26 (0.55 to 3.97) · 210 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.29 (0 to 17.86) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.01 (0.76 to 9.25) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.84 (0 to 1.89) · 1,236 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 305 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 167 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.8 · 176 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15 · 308 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.1 to 7.9) · 48 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.7 (6.4 to 14.7) · 48 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.4 to 18.8) · 339 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 388 cases | No different | Jan 2024 – Dec 2024 |
What patients said (496 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 93% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for St Luke'S Regional Medical Center
Behind the star rating — Deaths: 1 better, 6 the same, 1 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 5 better, 6 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.459 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.203 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.407 | Better | Oct 2024 – Sep 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.1 (6.8 to 9.7) · 1,092 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.61 (0.78 to 2.43) · 2,278 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.6 to 1.09) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.38 (95.48 to 183.27) · 160 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.7 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.8 · 122 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 345 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 15 · 508 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 534 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 796 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,937 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,027 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 9,267 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.48 (1.85 to 5.1) · 2,997 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0 to 2.7) · 1,577 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.52 (1.25 to 3.8) · 2,793 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.3 (1.86 to 10.74) · 1,482 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.78 (2.15 to 7.42) · 1,483 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.4 (0.03 to 2.76) · 843 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 7,363 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.7 · 124 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.668 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.703 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.938 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.1 · 607 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 17.8 · 965 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -3 · 373 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -48.3 · 559 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -23.7 · 546 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 901 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.1 to 6.4) · 1,092 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.8 · 131 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.2 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.3 to 18.2) · 361 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.1) · 2,189 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,628 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 5 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 92% |
| Yes, staff "did" give patients information about help after discharge | 92% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$15,402
Medicare paid this office $15,402 for 150 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 60 | $6,526 | $91 |
| Return visit (30+ min) | 70 | $5,425 | $59 |
| Short return visit (20+ min) | 45 | $1,980 | $40 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 18 | $353 | $20 |
Who their Medicare patients are
150 Original Medicare patients in 2024. Average age 76 · Under 65 10% · 85 and older 27% · Women 47% · Also on Medicaid 14% · Health risk score 2.29. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Heart failure 75% · Atrial fibrillation 57% · Chronic kidney disease 54% · Coronary heart disease 51% · Diabetes 41% · Depression 41% · COPD 29% · Cancer 15% · Dementia 13% · Stroke 9%.
The office billed $56,353, Medicare allowed $19,762 and paid $15,402; for 254 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 150 | 254 | 76 | 2.29 | $56,353 | $15,402 |
| 2023 | 85 | 135 | 72 | 1.66 | $28,948 | $8,080 |
| 2022 | 78 | 115 | 72 | 1.31 | $23,366 | $7,336 |
| 2021 | 30 | 40 | 73 | 1.01 | $7,737 | $2,541 |
| 2019 | 13 | 13 | 73 | 0.66 | $1,552 | $542 |
| 2017 | 84 | 167 | 78 | 2.38 | $33,978 | $11,718 |
| 2016 | 117 | 249 | 76 | 2.82 | $54,850 | $19,755 |
| 2015 | 115 | 168 | 77 | 2.47 | $37,550 | $14,351 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $2,348 | $107 |
| Short return visit (20+ min) | 24 | $1,065 | $38 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,029 | $69 |
| Return visit (30+ min) | 14 | $941 | $59 |
2022: 4 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $2,902 | $121 |
| Hospital discharge day management, more than 30 minutes | 12 | $802 | $67 |
| Hospital discharge day management, 30 minutes or less | 15 | $683 | $46 |
| Short return visit (20+ min) | 11 | $386 | $32 |
2017: 6 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $5,041 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,683 | $62 |
| Extended inpatient or observation hospital service, first hour | 24 | $1,440 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,401 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $901 | $38 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $473 | $25 |
2016: 6 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $9,936 | $129 |
| Extended inpatient or observation hospital service, first hour | 48 | $3,224 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $2,787 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,219 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $921 | $46 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $602 | $25 |
2015: 6 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $7,300 | $128 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $2,494 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $1,931 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $741 | $46 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $741 | $62 |
| Extended inpatient or observation hospital service, first hour | 12 | $704 | $59 |
Medicaid work
$1,040 in 2021
Medicaid paid $1,040 for 52 billed services this clinician did in 2021, up to 26 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose | 14 | $560 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; first dose | 12 | $480 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted, for intramuscular use | 26 | $0 |
| 2021 | 52 | 3 | 26 | $1,040 |
Drugs they prescribed that Part D paid
$310,306
Pharmacies billed $310,306 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
956 generic and 292 brand-name prescriptions · $310,306 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 65 | $69,314 | $1,066 |
| Entresto | 42 | $62,652 | $1,492 |
| Eliquis | 54 | $60,188 | $1,115 |
| Jardiance | 51 | $55,253 | $1,083 |
| Mounjaro | 12 | $12,336 | $1,028 |
See all 16 drugs
| Farxiga | 65 | $69,314 | $1,066 |
| Entresto | 42 | $62,652 | $1,492 |
| Eliquis | 54 | $60,188 | $1,115 |
| Jardiance | 51 | $55,253 | $1,083 |
| Mounjaro | 12 | $12,336 | $1,028 |
| Bumetanide | 132 | $8,083 | $61 |
| Eplerenone | 12 | $2,442 | $203 |
| Metoprolol | 111 | $1,437 | $13 |
| Potassium Chloride | 48 | $1,267 | $26 |
| Spironolactone | 179 | $1,084 | $6 |
| Furosemide | 113 | $612 | $5 |
| Gabapentin | 18 | $423 | $23 |
| Losartan | 39 | $278 | $7 |
| Atorvastatin | 37 | $273 | $7 |
| Lisinopril | 27 | $222 | $8 |
| Carvedilol | 33 | $206 | $6 |
Year by year
| 2024 | 1,248 | 288 | None | 23% | $310,306 |
| 2023 | 567 | 97 | 3% (16) | 8% | $26,470 |
| 2022 | 471 | 78 | 3% (13) | 11% | $22,765 |
| 2021 | 133 | 41 | None | None | $7,001 |
| 2020 | 78 | 52 | 0% (0) | 32% | $4,812 |
| 2019 | 270 | 152 | 0% (0) | None | $15,800 |
| 2018 | 250 | 135 | 0% (0) | None | $14,374 |
| 2017 | 58 | 37 | None | None | $2,515 |
| 2014 | 11 | None | 0% (0) | 0% | $148 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Eliquis | 14 | $8,426 | $602 |
| Baclofen | 31 | $1,043 | $34 |
| Gabapentin | 34 | $679 | $20 |
| Atorvastatin | 60 | $527 | $9 |
| Clopidogrel | 17 | $281 | $17 |
| Tamsulosin | 13 | $180 | $14 |
| Pantoprazole | 21 | $175 | $8 |
| Levothyroxine | 16 | $160 | $10 |
| Amlodipine Besylate | 31 | $140 | $5 |
| Trazodone | 14 | $130 | $9 |
| Lisinopril | 23 | $72 | $3 |
2022: 11 drugs
| Eliquis | 13 | $7,998 | $615 |
| Gabapentin | 34 | $949 | $28 |
| Baclofen | 24 | $942 | $39 |
| Atorvastatin | 36 | $237 | $7 |
| Levothyroxine | 17 | $178 | $10 |
| Metoprolol | 12 | $136 | $11 |
| Cyclobenzaprine | 18 | $90 | $5 |
| Losartan | 19 | $87 | $5 |
| Amlodipine Besylate | 21 | $52 | $2 |
| Trazodone | 13 | $39 | $3 |
| Lisinopril | 11 | $26 | $2 |
2021: 2 drugs
| Atovaquone-Proguanil | 12 | $794 | $66 |
| Azithromycin | 19 | $117 | $6 |
2020: 2 drugs
| Atovaquone-Proguanil | 12 | $931 | $78 |
| Azithromycin | 32 | $253 | $8 |
2019: 7 drugs
| Atovaquone-Proguanil | 53 | $4,146 | $78 |
| Shingrix | 15 | $2,780 | $185 |
| Typhim Vi | 12 | $1,509 | $126 |
| Vaqta | 15 | $1,384 | $92 |
| Azithromycin | 108 | $765 | $7 |
| Boostrix Tdap | 12 | $678 | $56 |
| Acetazolamide | 16 | $248 | $16 |
2018: 5 drugs
| Atovaquone-Proguanil | 51 | $4,146 | $81 |
| Twinrix | 17 | $2,101 | $124 |
| Typhim Vi | 11 | $1,332 | $121 |
| Boostrix Tdap | 15 | $854 | $57 |
| Azithromycin | 111 | $705 | $6 |
2017: 2 drugs
| Atovaquone-Proguanil | 13 | $820 | $63 |
| Azithromycin | 33 | $290 | $9 |
Money from drug and device companies
$1,955 in 2023
A payment is not proof that care is biased.
| Medtronic | Synchromedii | $1,935 | 12 payments
|
| ConvaTec | Gentlecath | $20 | 1 payment
|
See all 13 published payments
| Medtronic | Travel · 2023-05-02 | Synchromedii | $518 |
| Medtronic | Travel · 2023-05-02 | Synchromedii | $66 |
| Medtronic | Meals · 2023-05-02 | Synchromedii | $85 |
| Medtronic | Meals · 2023-05-02 | Synchromedii | $156 |
| Medtronic | Meals · 2023-05-02 | Synchromedii | $35 |
| Medtronic | Meals · 2023-05-02 | Synchromedii | $60 |
| Medtronic | Meals · 2023-05-02 | Synchromedii | $10 |
| Medtronic | Meals · 2023-05-02 | Synchromedii | $83 |
| ConvaTec | Meals · 2023-04-27 | Gentlecath | $20 |
| Medtronic | Education · 2023-04-14 | Synchromedii | $45 |
| Medtronic | Travel · 2023-04-14 | Synchromedii | $30 |
| Medtronic | Travel · 2023-04-10 | Synchromedii | $805 |
| Medtronic | Travel · 2023-04-10 | Synchromedii | $42 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1780006916
- Licence
- CA 23215California A23215: Deceased
- Trained
- University of Missouri, Columbia School of Medicine, 2013 · 13 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LA2200X (363LA2200X)
- Mailing address
- 875 Blake Wilbur Drive, Clinic E, Stanford, CA, 94305
- NPI first listed
- 2014-01-07
- NPI last updated
- 2014-07-24
This is when the NPI record was last certified, not a medical board exam.